Feasibility and Safety of Endoscopic Vacuum Treatment (EVT) of Walled-Off Necrosis in Acute Necrotizing Pancreatitis
Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S71-S72
DOI: 10.1055/s-0046-1820752 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von P Ewald und 12 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
Infected walled-off necrosis (WON) represents one of the most challenging complications of acute necrotizing pancreatitis (ANP). Endoscopic drainage of WON is usually done with a lumen-apposing metal stent (LAMS). Subsequent management following LAMS placement remains highly heterogeneous. Recent studies suggest that an accelerated approach, aiming for early removal of intracavitary debris and necrosis, may improve outcomes [ 1 ]. Endoscopic vacuum therapy (EVT) has become an established treatment approach for insufficiencies, leaks and cavities, but has not been evaluated for WON. In this study, we analyzed data from patients with WON and ANP who underwent EVT as an adjunctive treatment modality.
Methods
Between 2022 and 2024, data were collected in a multicenter, retrospective case series from four tertiary care centers in Germany and Brazil. Patients with infected WON and ANP (Revised Atlanta Classification), treated with EVT, were included. The primary endpoint was clinical success defined as a conjunctive endpoint of sepsis control, complete resolution of WON and fistula closure. Secondary endpoint was intracavitary bleeding, defined as hemorrhage requiring endoscopic, radiological or surgical intervention. The decision to commence EVT was based on spontaneous perforation of WON into the gastrointestinal tract in five patients, treatment-refractory sepsis in five patients, extensive size of WON in four patients, and treatment-refractory WON in two patients.
Results
Sixteen patients (10 male, 6 female, mean age 57,2 years) with infected WON and ANP were included. In total, 87 EsoSponge devices (79 intracavitary, 8 intraluminal), 38 individualized open-pore film drainage (OFD) devices (intracavitary), and 4 VacStent devices (intraluminal) were utilized. A median of 6,8 device exchanges or removal (range 1 – 26) were necessary. 12 patients underwent at least one session of direct endoscopic necrosectomy (DEN) with a total of 81 necrosectomy procedures performed. Clinical success was achieved in 14 of 16 patients within a median time of 30,6 days. Two patients died on days 15 and 37 after EVT initiation due to ongoing, uncontrollable sepsis. One further patient died two months after successful treatment of WON due to pulmonary sepsis. In a total of 108 EVT device exchanges or removals and 81 DEN, intracavitary bleeding occurred in two patients. In one patient, bleeding after EsoSponge removal was successfully managed endoscopically using a standard hemoclip. In the second patient, bleeding following OFD removal was insufficiently controlled endoscopically and ultimately required interventional radiology. Although the per-patient bleeding rate was 12,5%, the bleeding rate relative to the number of EVT interventions (per-procedure bleeding rate) was only 1,9%, lower than previously anticipated. The per-procedure bleeding rate is at the same level as in the established management of leaks in the upper gastrointestinal tract at 1,8% [ 2 ].
Conclusions
This study demonstrates the potential of EVT as an additional therapeutic step for managing WON. The small sample size of 16 patients and the retrospective analysis of a heterogeneous cohort treated with various multimodal approaches weaken the robustness of the findings. This feasibility study supports the need for larger, multicenter, prospective trials to confirm the benefits of EVT in this challenging patient population. Publication History Article published online: 05 June 2026 © 2026. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Ewald, P., Cahyadi, O., Zeidler, C., Tophof, M., Ayoub, M., Nagl, S., Scheppach, M. W., Wedemeyer, J., Moura, D. T. H. D., Moura, E. G. H. D., Messmann, H., Uhl, W., & Ebigbo, A. (2026). Feasibility and Safety of Endoscopic Vacuum Treatment (EVT) of Walled-Off Necrosis in Acute Necrotizing Pancreatitis. Endoscopy, 58(S 03 S 03), S71-S72. https://doi.org/10.1055/s-0046-1820752
Vancouver
Ewald P, Cahyadi O, Zeidler C, Tophof M, Ayoub M, Nagl S, et al. Feasibility and Safety of Endoscopic Vacuum Treatment (EVT) of Walled-Off Necrosis in Acute Necrotizing Pancreatitis. Endoscopy. 2026;58(S 03 S 03):S71-S72. doi:10.1055/s-0046-1820752
BibTeX
@article{Ewald2026,
author = {Ewald, P and Cahyadi, O and Zeidler, C and Tophof, M and Ayoub, M and Nagl, S and Scheppach, M W and Wedemeyer, J and Moura, D T Hourneaux De and Moura, E G Hourneaux de and Messmann, H and Uhl, W and Ebigbo, A},
title = {Feasibility and Safety of Endoscopic Vacuum Treatment (EVT) of Walled-Off Necrosis in Acute Necrotizing Pancreatitis},
journal = {Endoscopy},
year = {2026},
volume = {58},
number = {S 03 S 03},
pages = {S71--S72},
doi = {10.1055/s-0046-1820752}
}
EUVIMED